This work investigates the methodology of defining drug effects on animal behavior to improve the discovery and assessment of clinically valuable pharmacological agents. Susan D. Iversen, a recognized expert in the field, synthesizes existing research to bridge the gap between neuropharmacological action and observable behavioral outcomes. The text provides a framework for researchers to develop standardized animal model systems that accurately measure drug efficacy and modification. By integrating neuropharmacological principles with behavioral assays, the author establishes a rigorous approach to evaluating substances intended for the treatment of mental illness.

Experts recognize this text as a foundational resource for researchers focusing on the intersection of behavioral science and drug development. Readers frequently note the technical density of the prose, which is intended for an audience with a background in pharmacology or neuroscience.